China Summit : China Summit @ BIO International

jun 4, 2018: 11:45 a.m. - 5 p.m.
Room 253ABC, Level 2

Join us to bridge innovation, enterprise and culture from Boston, one of the most distinguished biotechnology hubs in the world, to China, one of the largest pharmaceutical market in the world. The Summit will examine recent watersheds in China’s regulatory, policy, and industrial reforms positioned to create a globally competitive biopharmaceutical industry in China, as well as successful models for cross-border alliances and partnerships blazing a path toward biotech growth and innovation. 

๐๐ซ๐จ๐ ๐ซ๐š๐ฆ
*๐˜š๐˜ถ๐˜ฃ๐˜ซ๐˜ฆ๐˜ค๐˜ต ๐˜ต๐˜ฐ ๐˜ค๐˜ฉ๐˜ข๐˜ฏ๐˜จ๐˜ฆ; ๐˜ค๐˜ฉ๐˜ฆ๐˜ค๐˜ฌ ๐˜ต๐˜ฉ๐˜ฆ ๐˜‰๐˜๐˜– ๐˜Š๐˜ฐ๐˜ฏ๐˜ท๐˜ฆ๐˜ฏ๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ฐ๐˜ฏ๐˜ญ๐˜ช๐˜ฏ๐˜ฆ ๐˜ฅ๐˜ฆ๐˜ด๐˜ค๐˜ณ๐˜ช๐˜ฑ๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ง๐˜ฐ๐˜ณ ๐˜ญ๐˜ข๐˜ต๐˜ฆ๐˜ด๐˜ต ๐˜ถ๐˜ฑ๐˜ฅ๐˜ข๐˜ต๐˜ฆ๐˜ฅ ๐˜ข๐˜จ๐˜ฆ๐˜ฏ๐˜ฅ๐˜ข 
**๐˜–๐˜ฑ๐˜ฆ๐˜ฏ ๐˜ต๐˜ฐ ๐˜ข๐˜ญ๐˜ญ ๐˜ข๐˜ต๐˜ต๐˜ฆ๐˜ฏ๐˜ฅ๐˜ฆ๐˜ฆ๐˜ด, ๐˜ช๐˜ฏ๐˜ค๐˜ญ๐˜ถ๐˜ฅ๐˜ช๐˜ฏ๐˜จ ๐˜Œ๐˜น๐˜ฉ๐˜ช๐˜ฃ๐˜ช๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ˆ๐˜ค๐˜ค๐˜ฆ๐˜ด๐˜ด

The China Summit @ BIO International is a half-day program at the BIO International Convention to explore recent regulatory changes, investment trends, and cross-border collaborations in the life sciences sector. The gathering of industry leaders, experts and decision-makers will deliver a robust agenda featuring keynote presentations as well as panel debates on opportunities and challenges facing the biomedical industry in China. 

ไธญๅ›ฝ้ซ˜ๅณฐไผšๆ˜ฏๅœจBIO ๅ›ฝ้™…็”Ÿ็‰ฉๆŠ€ๆœฏๅฑ•่งˆๅคงไผšๅนณๅฐไธŠ็š„ไธ€ไธชไธป้ข˜่ฎบๅ›๏ผŒๆ—จๅœจๆŽข็ดขไธŽๅ‰–ๆžไธญๅ›ฝๅŒป่ฏ็•Œ่ฟ‘ๆœŸ็š„ไฝ“ๅˆถๆ”น้ฉ๏ผŒๆŠ•่ต„ๅ‰ๆ™ฏๅ’Œ่ทจๅขƒๅˆไฝœ็ญ‰็ญ‰่ถ‹ๅŠฟๅฑ•ๆœ›ใ€‚ ๆœฌ้ซ˜ๅณฐไผš่š้›†ไบ†่กŒไธš้ข†ๅฏผ่€…ๅŠไธ“ๅฎถไปฌ็ป„ๆˆไธ€ไธชๅคšๅ…ƒๅŒ–็š„ไผš่ฎฎ่ฎฎ็จ‹๏ผŒๅฐฑไธญๅ›ฝ็”Ÿ็‰ฉๅŒป่ฏ่กŒไธš้ขไธด็š„ๆœบ้‡ๅ’ŒๆŒ‘ๆˆ˜ๅฑ•ๅผ€ๅฐ็ป„่ฎจ่ฎบใ€‚ ๆฌข่ฟŽๅคงๅฎถ่ธŠ่ทƒๅ‚ๅŠ ใ€‚

11:45 to 12:00pm - ๐Ž๐ฉ๐ž๐ง ๐’๐ž๐š๐ญ๐ข๐ง๐  ๐๐ž๐ ๐ข๐ง๐ฌ
(Pick-up Box Lunches) 

12:00 to 12:25pm - ๐Ž๐ฉ๐ž๐ง๐ข๐ง๐  ๐‘๐ž๐ฆ๐š๐ซ๐ค๐ฌ
• Joe Damond, Executive VP for International Affairs, BIO
• Victor Shi, Chairman, Bayhelix Group; Founding President Asia Pacific QIAGEN

12:35 to 1:10pm - ๐…๐ข๐ซ๐ž๐ฌ๐ข๐๐ž ๐‚๐ก๐š๐ญ: ๐๐ฅ๐ฎ๐ž๐ฉ๐ซ๐ข๐ง๐ญ ๐Ÿ๐จ๐ซ ๐‚๐ก๐ข๐ง๐š’๐ฌ ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐‘๐ž๐Ÿ๐จ๐ซ๐ฆ
• Director General GE Yanfeng, Social Development Research Division, Development Research Center of the State Council
• Moderator: Monica He, Director for International Affairs, BIO

1:15 to 2:10pm - ๐Š๐ž๐ฒ ๐ˆ๐ฌ๐ฌ๐ฎ๐ž๐ฌ ๐“๐จ๐๐š๐ฒ: ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ, ๐ˆ๐, ๐š๐ง๐ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง
• Alan Turley, Deputy Assistant Secretary for China, U.S. Department of Commerce
• Tony Chen, Partner, Jones Day Shanghai
• Lijun Wu, Chief Scientific Officer, Fosun Pharma USA
• Yuan-Hua Ding, Executive Director and Head of External Science & Innovation, Pfizer
• Haishan Xiong, Senior VP for Business Development, Fountain Medical Development
• Moderator: Kewen Jin, Managing Partner, Serica Partners

2:15 to 3:30pm - ๐๐ž๐ฐ ๐„๐œ๐จ๐ง๐จ๐ฆ๐ฒ ๐‹๐ข๐Ÿ๐ž ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ ๐“๐ซ๐š๐ง๐ฌ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐†๐ฅ๐จ๐›๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ๐ฌ

2:15-2:30pm - Presentation: Heading East: Biopharma International Expansion to China and Asia
• Helen Chen, Head of China and Asia Life Sciences, L.E.K. Consulting

• Edward Hu, Chief Financial Officer and Chief Investment Officer, WuXi AppTec
• Greg Scott, Founder and Chairman, ChinaBio Group
• Micah Mackison, Senior VP for Corporate Development and Strategy, Assembly Biosciences
• Jonathan Wang, Senior VP and Head of Business Development Zai Lab
• Donghui Qin, Director of Innovation, Ferring Pharmaceuticals
• Moderator: Helen Chen, Head of China and Asia Life Sciences, L.E.K. Consulting

3:35 to 4:45pm - ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐…๐ข๐ง๐š๐ง๐œ๐ข๐ง๐ , ๐‚๐š๐ฉ๐ข๐ญ๐š๐ฅ ๐Œ๐š๐ซ๐ค๐ž๐ญ๐ฌ ๐š๐ง๐ ๐‚๐ซ๐จ๐ฌ๐ฌ ๐๐จ๐ซ๐๐ž๐ซ ๐๐ƒ
• Michael Chan, Senior VP, HKEX 
• Katherine Andersen, Head of Healthcare Corporate Finance and East/Central Life Science, Silicon Valley Bank
• Wei Li, Founding Partner, 6 Dimensions Capital
• Wendy Pan, Partner, Sidley
• Alexandra Jung, Managing Director, EY-Parthenon
• Moderator: Debra Yu, Managing Director, China Renaissance Securities (US) Inc.

5:00 to 6:30pm - ๐‚๐ก๐ข๐ง๐š ๐•๐ˆ๐ ๐‘๐ž๐œ๐ž๐ฉ๐ญ๐ข๐จ๐ง @ ๐๐ˆ๐Ž ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ (*Invitation Only*)